Bidault, Guillaume http://orcid.org/0000-0002-8396-9962
Virtue, Samuel http://orcid.org/0000-0002-9545-5432
Petkevicius, Kasparas http://orcid.org/0000-0003-2295-6065
Jolin, Helen E.
Dugourd, Aurélien
Guénantin, Anne-Claire
Leggat, Jennifer http://orcid.org/0000-0002-1040-6827
Mahler-Araujo, Betania
Lam, Brian Y. H.
Ma, Marcella K. http://orcid.org/0000-0002-2228-7466
Dale, Martin
Carobbio, Stefania
Kaser, Arthur
Fallon, Padraic G.
Saez-Rodriguez, Julio http://orcid.org/0000-0002-8552-8976
McKenzie, Andrew N. J. http://orcid.org/0000-0001-9757-2512
Vidal-Puig, Antonio http://orcid.org/0000-0003-4220-9577
Article History
Received: 21 December 2019
Accepted: 22 July 2021
First Online: 16 September 2021
Competing interests
: K.P. is currently employed by AstraZeneca. J.S.-R. has received funding from GSK and Sanofi and consultant fees from Travere Therapeutics. The other authors declare no competing interests.